An Open Label Extension of the LAQ/5062 and LAQ/5063 Studies to Assess the Long Term Safety and Tolerability of Laquinimod 0.6mg in RRMS Patients ClinicalTrials.gov, 13 Feb 2012 Accessed on 21 Feb 2012 from http://www.clinicaltrials.gov/ct2/show/NCT00745615. CommentRecommendBookmarkWatch